top of page

Services

Our focus is to provide medical/clinical affairs consulting expertise to medical device, IVD and Pharma (especially with companion diagnostics) companies on medical risk determinations and pre-submission expertise for new IVD assays.

We have experience in the design and execution of over 30 clinical trials spanning Pharmaceutical (phase 1-4), medical device (IDE) and IVD (IDE and PMA). This experience helps our clients solve complex clinical/regulatory challenges that they encounter. Our experience spans a wide array of products, across a wide array of therapeutic areas.

 

Our therapeutic experience includes cardiovascular, anesthesia/pain, critical care, infectious disease, oncology and maternal-fetal medicine.

New Product Development
  • Clinical needs assessment:

    • Target product profile

    • User needs

    • Product requirements

  • Regulatory strategy – clinical plans

  • Risk management plans

    • Including, on-market product safety

Clinical Trial Strategy
  • Clinical development plans

  • IND, IDE and PMA

  • Protocol design

  • Medical monitoring

  • Clinical data analysis

  • Clinical study report preparation

Clinical Marketing
  • Clinical value proposition

  • Competitive market analysis

  • Voice of customer research

  • Advisory board development

  • Publication planning

  • Post-market study planning

New Ventures
New Ventures
  • Due diligence support for business development activities

  • Startup creation and operation

  • New venture funding

Download

Click to the icon to download a summary of our Expert Competencies
  • Medical Device Innovators preparing for launch and clinical adoption

  • Diagnostics / IVD teams translating evidence into adoption

  • Biotech & Pharma teams supporting evidence-based education and sales

  • Investor-backed startups requiring credible clinical narratives for regulatory approval, launch and commercial growth

Who This is For

© 2025 by RNB Ventures Consulting, Inc.

    • LinkedIn Social Icon

    Why Physician-Led Matters

    We interpret science and translate that into a cogent and authentic story.

    Our work is led by physicians with decades of experience in medical affairs leadership, regulatory engagement, and clinical development inside global healthcare organizations.

    Physician Profile
    Robert Bilkovski, MD, MBA

    Dr. Bilkovski brings over two decades of leadership across medical affairs, clinical development, and regulatory strategy spanning medical devices, IVD, and pharmaceuticals.

    Former Medical Director roles include:

    • Becton Dickinson

    • Abbott Laboratories

    • GE Healthcare

    • Hospira (Pfizer)


    He is a subject-matter expert in Advertising & Promotion (AdPromo) and served as a panelist at RAPS Convergence addressing compliant clinical communication strategies.

    RBilkovski_2020-JAN.jpg

    Media Examples

    Physician Profile
    Joseph J. Pinzone, MD, MBA, FACP

    Dr. Pinzone combines academic medicine, industry leadership, and national media experience.

    Training:

    • NYU School of Medicine

    • Columbia-Presbyterian Medical Center (Internal Medicine)

    • Massachusetts General Hospital / Harvard Medical School (Endocrinology, NIH-funded research)


    Former Head of Medical Affairs at Amgen (XGEVA®). Hosted PBS programming and served as a national medical expert across television and digital media platforms.

    Headshot - Pinzone_edited_edited_edited.

    Media Examples

    Partnership with
    Good Chemistry Communications

    Good Chemistry Communications specializes in clinical publications and scientific content for pharmaceutical, biotechnology, medical device, and consumer products companies.

    Services include:

    • Clinical manuscript development for peer-reviewed journals

    • Evidence compendia for regulatory and reimbursement submissions

    • Conference abstracts, posters, and presentations

    • White papers and scientific summaries

    Eric Moorhead brings over 10 years of medical device and pharmaceutical experience, with a track record of successful publications in high-impact journals.

    bottom of page